Memantin Sandoz (Memantine Hydrochloride)

Memantine works by non‑competitively blocking the NMDA‑type glutamate receptor. This limits excessive calcium entry into neurons that occurs during prolonged glutamate exposure, thereby reducing excitotoxic damage while allowing normal synaptic activity needed for learning and memory.

The dose of Memantin Sandoz is individualized by a qualified prescriber based on the patient’s clinical condition, renal function, and tolerability. Physicians typically start with a low dose and titrate upward, but exact dosing regimens are not disclosed here.

Safety data for memantine during pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To order Memantin Sandoz, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative class for Alzheimer’s disease is acetylcholinesterase inhibitors such as donepezil. While those agents increase acetylcholine levels, memantine modulates glutamatergic activity. Clinicians may use them together for complementary mechanisms, but memantine is generally preferred for moderate to severe stages where excitotoxicity is more prominent.

Memantin Sandoz tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains sealed until use.

The medication is taken orally as a tablet, swallowed whole with a glass of water. It may be taken with or without food, and patients should follow the dosing schedule prescribed by their healthcare professional.

Serious adverse events, although uncommon, include seizures, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and hallucinations. Patients should seek immediate medical attention if they experience any of these symptoms.

Memantin Sandoz should be avoided in individuals with known hypersensitivity to memantine or any tablet excipients. Caution is also advised for patients with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists without medical supervision.